• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

    4/3/24 7:00:00 AM ET
    $ASPI
    $AYTU
    $CIA
    $CREV
    Major Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ASPI alert in real time by email

    MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 2

    April 4, 2024

    10:30

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    10:45

    Introduction

    10:50 – 11:20

    Strawberry Fields REIT, Inc., (NYSE:STRW)

    Keynote speaker: Moishe Gubin, Chairman, CEO

    11:25 - 11:55

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Gerald W. Shields, Vice Chairman and CEO Jeff Conklin, CFO

    12:00 – 12:30

    LeddarTech Holdings, Inc. (NASDAQ:LDTC)

    Keynote speakers: Frantz Saintellemy – CEO & Chris Stewart, CFO

    1:10 - 1:40

    Bioxytran, Inc. (OTCQB:BIXT)

    Keynote speaker: Mike Sheikh, Executive Vice President Business Development

    1:45 - 2:15

    Alpha Seven Therapeutics, Inc.

    Keynote speaker: Michael E. McFadden, CEO & Director

    2:55 - 3:05

    Clearday, Inc. (OTCQX:CLRD)

    Keynote speakers: James Walesa, President / CEO, and Dan Policy, Corporate Development

    3:10 - 3:20

    Shuttle Pharmaceuticals, Inc. (NASDAQ:SHPH)

    Keynote speaker: Anatoly Dritschilo, MD, CEO & Chairman

    3:40 - 3:50

    FendX Technologies, Inc. (OTCQB:FDXTF) (CSE:FNDX)

    Keynote speaker: Carolyn Myers, CEO

    3:55 - 4:05

    Atacama Resources International, Inc. (OTC:ACRL)

    Keynote speaker: Greg Praver, Investor Relations

    4:10 – 4:20

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, Harry M. Lander, Ph.D. Senior Scientific Consultant, and Annette Marleau, PHD

    4:25 – 4:35

    Carbon Revolution, Plc. (NASDAQ:CREV)

    Keynote speakers: Gerald Buckle, CFO, and Nick Batchelor, Commercial Director

    4:40 – 4:50

    Aytu BioPharma (NASDAQ:AYTU)

    Keynote speaker: Joshua Disbrow, Chairman, CEO

    Presented Yesterday, April 3, 2024.

    Glucotrack, Inc. (NASDAQ:GCTK)

    Keynote speaker: Mark Tapsak, PhD, VP of Sensor Technology

    ASP Isotopes Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    Alpha Cognition Inc. (OTCQB:ACOGF) (CSE:ACOG)

    Keynote speakers: Michael E. McFadden, CEO & Director & Lauren D'Angelo, COO

    SinglePoint Inc. (CBOE: SING)

    Keynote speaker: Wil Ralston, CEO

    Element79 Gold Corp. (OTC:ELMGF) (CSE:ELEM)

    Keynote speaker: James Tworek, CEO

    AseptiScope, Inc.

    Keynote speaker: Scott W Mader – Founder & CEO

    Ideal Power (NASDAQ:IPWR)

    Keynote speaker: Dan Brdar, President, CEO & Director

    ANGLE, PLC., (OTCQX:ANPCY) (AIM: AGL)

    Keynote speaker: Andrew Newland, Founder, CEO & Executive Director

    SensTech, Inc. (NASDAQ:SNES)

    Keynote speaker: Joel L. Fruendt, President, CEO, & Director

    CervoMed Inc. (NASDAQ:CRVO)

    Keynote speaker: John Alam, CEO

    Canoo Technologies, Inc. (NASDAQ:GOEV)

    Keynote speaker: Greg Ethridge, CFO

    Dermata Therapeutics, Inc. (NASDAQ:DRMA)

    Keynote speaker: Gerry Proehl, Founder, Chairman, President & CEO

    OptimumBank Holdings, Inc. (NASDAQ:OPHC)

    Keynote speaker: Moishe Gubin, Chairman of the Board.

    Myriad Uranium Corp. (OTCQB:MYRUF) (CSE:M)

    Keynote speaker: Thomas David Lamb, President, CEO, & Director

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ASPI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASPI
    $AYTU
    $CIA
    $CREV

    CompanyDatePrice TargetRatingAnalyst
    CervoMed Inc.
    $CRVO
    12/18/2025Overweight
    Cantor Fitzgerald
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    Strawberry Fields REIT Inc.
    $STRW
    10/1/2025$14.00Overweight
    Cantor Fitzgerald
    Strawberry Fields REIT Inc.
    $STRW
    7/2/2025$10.65Buy → Neutral
    Compass Point
    Aytu BioPharma Inc.
    $AYTU
    7/1/2025$8.00Buy
    Lake Street
    Aytu BioPharma Inc.
    $AYTU
    6/30/2025$12.00Buy
    Ascendiant Capital Markets
    CervoMed Inc.
    $CRVO
    3/13/2025$14.00Neutral → Buy
    Chardan Capital Markets
    Strawberry Fields REIT Inc.
    $STRW
    1/16/2025$14.00Buy
    Compass Point
    More analyst ratings

    $ASPI
    $AYTU
    $CIA
    $CREV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $ASPI
    $AYTU
    $CIA
    $CREV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Chief Commercial and Business Winton Matthew

    4 - CervoMed Inc. (0001053691) (Issuer)

    2/13/26 5:02:27 PM ET
    $CRVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASPI
    $AYTU
    $CIA
    $CREV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on CervoMed

    Cantor Fitzgerald initiated coverage of CervoMed with a rating of Overweight

    12/18/25 9:09:07 AM ET
    $CRVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald initiated coverage on ASP Isotopes with a new price target

    Cantor Fitzgerald initiated coverage of ASP Isotopes with a rating of Overweight and set a new price target of $13.00

    12/4/25 8:40:44 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Cantor Fitzgerald initiated coverage on Strawberry Fields REIT with a new price target

    Cantor Fitzgerald initiated coverage of Strawberry Fields REIT with a rating of Overweight and set a new price target of $14.00

    10/1/25 9:39:47 AM ET
    $STRW
    Real Estate Investment Trusts
    Real Estate

    $ASPI
    $AYTU
    $CIA
    $CREV
    SEC Filings

    View All

    Strawberry Fields REIT Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Strawberry Fields REIT, Inc. (0001782430) (Filer)

    2/19/26 4:31:50 PM ET
    $STRW
    Real Estate Investment Trusts
    Real Estate

    ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASP Isotopes Inc. (0001921865) (Filer)

    2/19/26 9:25:32 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Dermata Therapeutics Inc.

    SCHEDULE 13G/A - Dermata Therapeutics, Inc. (0001853816) (Subject)

    2/18/26 4:49:52 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASPI
    $AYTU
    $CIA
    $CREV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Strawberry Fields REIT Announces 2025 Year-End Operating Results

    SOUTH BEND, Ind., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE:STRW) (the "Company") reported today its operating results for the year ended December 31, 2025. Select 2025 Financial Highlights 100% of contractual rents collected.On January 1, 2025, the Company entered into a new master lease for 10 Kentucky properties formally part of the Landmark Master Lease. Base rent is $23.3 million a year and is subject to an increase based on CPI with a minimum increase of 2.50%. The initial lease term is 10 years with four 5-year extension options. Also, as part of the negotiation of the new Kentucky Master Lease, the Company entered into a 5 year note payable with the par

    2/19/26 4:30:00 PM ET
    $STRW
    Real Estate Investment Trusts
    Real Estate

    ASP Isotopes Announces Establishment of Quantum Leap Energy Strategic Advisory Board, Bolstering its Plans for the Nuclear Fuel Sector

    DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI") today announced that Quantum Leap Energy LLC ("QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has formed a Strategic Advisory Board ("SAB)", and appointed, as initial SAB members, two distinguished nuclear fuel and advanced materials industry leaders: Mary Lou Dunzik-Gougar and Kevin Kramer. The SAB is expected to provide guidance and insights as QLE aims to address gaps in the nuclear fuel cycle, promote safe nuclear power, and enhance the sustainability of the nucle

    2/19/26 8:45:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    SenesTech Reports Significant Reductions in Rodent Activity Following Evolve® Deployments in Urban Field Studies

    SURPRISE, Ariz., Feb. 18, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) ("SenesTech" or the "Company"), a leader in birth control solutions for managing rodent populations, today reported significant reductions in rodent activity following multi-month deployments of Evolve® Rat Birth Control in two urban locations. Results were measured using standardized tracking plate data conducted over a five-month period. Location A – Deployment Initiated April 2025In the first monitored area, where Evolve placement began in April 2025, tracking plate data collected from August 2025 th

    2/18/26 8:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $ASPI
    $AYTU
    $CIA
    $CREV
    Financials

    Live finance-specific insights

    View All

    Strawberry Fields REIT Announces 2025 Year-End Operating Results

    SOUTH BEND, Ind., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE:STRW) (the "Company") reported today its operating results for the year ended December 31, 2025. Select 2025 Financial Highlights 100% of contractual rents collected.On January 1, 2025, the Company entered into a new master lease for 10 Kentucky properties formally part of the Landmark Master Lease. Base rent is $23.3 million a year and is subject to an increase based on CPI with a minimum increase of 2.50%. The initial lease term is 10 years with four 5-year extension options. Also, as part of the negotiation of the new Kentucky Master Lease, the Company entered into a 5 year note payable with the par

    2/19/26 4:30:00 PM ET
    $STRW
    Real Estate Investment Trusts
    Real Estate

    OptimumBank Holdings, Inc., Announced Fourth Quarter 2025 Results and Will Host Earnings Webcast on February 18, 2026

    Fort Lauderdale, Florida--(Newsfile Corp. - February 11, 2026) - OptimumBank Holdings, Inc. (NYSE:OPHC), today announced that its management team will host a conference call and live webcast on Wednesday, February 18, 2026, at 10:00 A.M. Eastern Time to discuss the Company's financial results for the fourth quarter and full year ended December 31, 2025, and provide a business update.The Company released its fourth-quarter and full-year earnings results on February 2, 2026.Earnings ReleaseThe Company's fourth-quarter and full-year earnings release issued on February 2, 2026, is available here: Earnings ReleaseCurrent and prospective investors are invited to attend the webcast virtually by reg

    2/11/26 8:30:00 AM ET
    $OPHC
    Major Banks
    Finance

    OptimumBank Holdings, Inc. Financial Performance for the Fourth Quarter of 2025

    Fort Lauderdale, FL, Feb. 02, 2026 (GLOBE NEWSWIRE) -- OptimumBank Holdings, Inc. (NYSE:OPHC) (the "Company") is a bank holding company. OptimumBank (the "Bank") is a Florida-chartered commercial bank and is owned 100% by the Company. The Company is pleased to announce net earnings of $4.85 million, or $0.42 per basic share, and $0.21 per diluted share, for the fourth quarter of 2025. This compares to net earnings of $4.32 million, or $0.37 per basic share, and $0.18 per diluted share, for the third quarter of 2025, and $3.95 million net earnings, or $0.38 per basic share, and $0.18 per diluted share, for the comparable quarter last year. For the twelve-month period ended December 31, 2025

    2/2/26 8:45:00 AM ET
    $OPHC
    Major Banks
    Finance

    $ASPI
    $AYTU
    $CIA
    $CREV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:12:23 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Dermata Therapeutics Inc.

    SC 13G/A - Dermata Therapeutics, Inc. (0001853816) (Subject)

    11/14/24 5:07:13 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASPI
    $AYTU
    $CIA
    $CREV
    Leadership Updates

    Live Leadership Updates

    View All

    CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, announces the appointment of Eric Francois to the Company's Board of Directors. "Eric's decades of financial, transactional and operational experience will make an immediate impact to CERo's board of directors," said Chris Ehrlich, Company Chairman and Chief Executive Officer. "Furthermore, his expertise in capital raising, M&A, and business development will be an impactful addition at this stage of our development." Mr. Francois is an executive with over 25

    2/17/26 8:00:00 AM ET
    $CERO
    $CRVO
    $SCYX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Shuttle Pharmaceuticals Acquires AI Health Platform

    Rockville, Maryland--(Newsfile Corp. - November 21, 2025) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle" or the "Company") today announced that it has closed the acquisition of the assets and liabilities of 1542770 B.C. Ltd. d/b/a Molecule.ai ("Molecule"), a Canadian artificial intelligence company specializing in molecular discovery and drug development technologies.Under the terms of the agreement, 1563868 B.C. Ltd., a wholly owned subsidiary of Shuttle, acquired substantially all of Molecule's assets and liabilities for a total purchase price of $8 million, payable in a combination of cash and shares of Shuttle common stock, plus an additional contingent $2 million, pay

    11/21/25 9:30:00 AM ET
    $SHPH
    Biotechnology: Pharmaceutical Preparations
    Health Care